Jianming Xu
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Surgery top 2%
- Molecular Biology top 10%
- Hepatology top 0.5%
- Co-authors
- Shukui QinYuxian BaiRui‐Hua XuYoon‐Koo KangHyun Cheol ChungEric Van CutsemHongming PanYing Cheng
- Topics
- Gastric Cancer Management and Outcomes (60 papers)Colorectal Cancer Treatments and Studies (55 papers)Cancer Immunotherapy and Biomarkers (38 papers)
- Cited by
- GastroenterologyOncologyHepatology
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Jianming Xu
202 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 3.8k
- Pulmonary and Respiratory Medicine 3.0k
- Surgery 1.5k
- Molecular Biology 1.1k
- Hepatology 1.1k
Countries citing papers authored by Jianming Xu
This map shows the geographic impact of Jianming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianming Xu more than expected).
Fields of papers citing papers by Jianming Xu
This network shows the impact of papers produced by Jianming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianming Xu. The network helps show where Jianming Xu may publish in the future.
Co-authorship network of co-authors of Jianming Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Jianming Xu. A scholar is included among the top collaborators of Jianming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianming Xu. Jianming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 25 | |
| 8 | The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancerbreakdown → | 449 |
| 9 | 70 | |
| 10 | 115 | |
| 11 | 9 | |
| 12 | 62 | |
| 13 | 23 | |
| 14 | 63 | |
| 15 | 7 | |
| 16 | A Multicenter Feasibility Study with S-1, Oxaliplatin and Oral Leucovorin (SOL) for the Patients with Untreated Metastatic Colorectal Cancer: The Result of Final Analysis. | 1 |
| 17 | 358 | |
| 18 | 5 | |
| 19 | [HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis]. | 1 |
| 20 | 1 |
About Jianming Xu
Jianming Xu is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 218 papers that have together received 6.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (60 papers), Colorectal Cancer Treatments and Studies (55 papers) and Cancer Immunotherapy and Biomarkers (38 papers). The work is most often cited by research in Gastroenterology (854 citations), Oncology (3.8k citations) and Hepatology (1.1k citations). Jianming Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shukui Qin, Yuxian Bai, Rui‐Hua Xu, Yoon‐Koo Kang, Hyun Cheol Chung, Eric Van Cutsem, Hongming Pan, Shukui Qin, Ying Cheng and Atsushi Ohtsu. Their work appears in journals such as Nature, The Lancet and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.